Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600
2025-08-27 01:18:30 ET
More on Elanco, Sarepta Therapeutics, etc.
- Sarepta Therapeutics: A Strong Opportunity Amidst The Panic
- Sarepta: A Dizzying Pivot From Gene Therapy Peril To An RNA Future (Rating Downgrade)
- Elanco Animal Health Incorporated 2025 Q2 - Results - Earnings Call Presentation
- Sarepta Therapeutics refinances $700M of convertible notes
- Sarepta sells Arrowhead stock, activates $100M milestone payment
Read the full article on Seeking Alpha
For further details see:
Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600NASDAQ: BHLB
BHLB Trading
0.11% G/L:
$26.53 Last:
211,986 Volume:
$26.39 Open:



